| Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients M Chaparro, I Ordás, E Cabré, V Garcia-Sanchez, G Bastida, M Peñalva, ... Inflammatory bowel diseases 19 (7), 1404-1410, 2013 | 336 | 2013 |
| Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease J Panés, A López–SanRomán, F Bermejo, V García–Sánchez, M Esteve, ... Gastroenterology 145 (4), 766-774. e1, 2013 | 290 | 2013 |
| Intestinal permeability is increased in patients with advanced cirrhosis. S Pascual, J Such, A Esteban, P Zapater, JA Casellas, JR Aparicio, ... Hepato-gastroenterology 50 (53), 1482-1486, 2003 | 222 | 2003 |
| Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy C Loras, JP Gisbert, M Mínguez, O Merino, L Bujanda, C Saro, ... Gut 59 (10), 1340-1346, 2010 | 206 | 2010 |
| Brain edema and inflammatory activation in bile duct ligated rats with diet‐induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis R Jover, R Rodrigo, V Felipo, R Insausti, J Sáez‐Valero, ... Hepatology 43 (6), 1257-1266, 2006 | 194 | 2006 |
| Long-term safety ofin uteroexposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study M Chaparro, A Verreth, T Lobaton, E Gravito-Soares, M Julsgaard, ... Official journal of the American College of Gastroenterology| ACG 113 (3 …, 2018 | 186 | 2018 |
| Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study C Loras, C Saro, F Gonzalez-Huix, M Mínguez, O Merino, JP Gisbert, ... Official journal of the American College of Gastroenterology| ACG 104 (1), 57-63, 2009 | 161 | 2009 |
| Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced Fibrosis I Gomez-Hurtado, A Santacruz, G Peiro, P Zapater, A Gutierrez, ... PloS one 6 (7), e23037, 2011 | 155 | 2011 |
| Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose “escalation” in patients losing response M Chaparro, J Panes, V García, M Manosa, M Esteve, O Merino, ... Journal of clinical gastroenterology 45 (2), 113-118, 2011 | 153 | 2011 |
| Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer L Bujanda, C Sarasqueta, L Zubiaurre, A Cosme, C Munoz, A Sanchez, ... Gut 56 (12), 1714-1718, 2007 | 134 | 2007 |
| Evolution after anti-TNF discontinuation in patients with inflammatory bowel disease: a multicenter long-term follow-up study MJ Casanova, M Chaparro, V García-Sánchez, O Nantes, E Leo, ... Official journal of the American College of Gastroenterology| ACG 112 (1 …, 2017 | 121 | 2017 |
| Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome O García-Bosch, JP Gisbert, À Cañas-Ventura, O Merino, JL Cabriada, ... Journal of Crohn's and Colitis 7 (9), 717-722, 2013 | 99 | 2013 |
| Clinical outcomes of golimumab as first, second or third anti-TNF agent in patients with moderate-to-severe ulcerative colitis C Taxonera, C Rodriguez, F Bertoletti, L Menchen, J Arribas, M Sierra, ... Inflammatory bowel diseases 23 (8), 1394-1402, 2017 | 93 | 2017 |
| Incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in patients with inflammatory bowel disease: a nationwide cohort study I Guerra, T Pérez-Jeldres, M Iborra, A Algaba, D Monfort, X Calvet, ... Inflammatory bowel diseases 22 (4), 894-901, 2016 | 93 | 2016 |
| Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry M Chaparro, A Garre, E Ricart, M Iborra, F Mesonero, I Vera, S Riestra, ... Alimentary pharmacology & therapeutics 48 (8), 839-851, 2018 | 92 | 2018 |
| Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences JR Aparicio, J Such, S Pascual, A Arroyo, J Plazas, E Girona, A Gutiérrez, ... Journal of hepatology 31 (2), 277-283, 1999 | 92 | 1999 |
| Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease A Gutiérrez, M Scharl, L Sempere, E Holler, P Zapater, I Almenta, ... Gut 63 (2), 272-280, 2014 | 84 | 2014 |
| Incidence, clinical characteristics and management of inflammatory bowel disease in Spain: large-scale epidemiological study M Chaparro, A Garre, A Núñez Ortiz, MT Diz-Lois Palomares, ... Journal of clinical medicine 10 (13), 2885, 2021 | 80 | 2021 |
| Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry M Iborra, B Beltrán, A Fernández‐Clotet, A Gutiérrez, B Antolín, ... Alimentary pharmacology & therapeutics 50 (3), 278-288, 2019 | 74 | 2019 |
| Long-term efficacy and safety of cyclosporine in a cohort of steroid-refractory acute severe ulcerative colitis patients from the ENEIDA registry (1989–2013): a nationwide … I Ordás, E Domènech, M Mañosa, V García-Sánchez, E Iglesias-Flores, ... Official journal of the American College of Gastroenterology| ACG 112 (11 …, 2017 | 69 | 2017 |
